At 4.0% CAGR, the Middle East & Africa Advanced Medical Stopcock Market is projected to be worth US$ 119.25 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa advanced medical stopcock market was valued at US$ 94.29 million in 2022 and is expected to reach US$ 119.25 million by 2028, registering a CAGR of 4.0% from 2022 to 2028. Increasing incidence of chronic diseases and increasing geriatric population and demand in number of surgical procedures are the critical factors attributed to the Middle East & Africa advanced medical stopcock market expansion.

Medical stopcocks are used with infusion pumps to administer medications through the catheter to a specific part of the body during or after surgical procedures. Infusion therapy is used when other methods are less effective or when the patient needs medication for the long term. Stopcocks are used after surgeries to provide medicines in fluid forms when the patient is under observation.

The age-adjusted death rate per 100,000 population was 239.8. Further, the age-adjusted prevalence rate was 7,354.1 per 100,000. Thus, the rising CVD patient population is increasing the number of angiography or angioplasty procedures. These procedures require high-pressure stopcocks; as a result, the demand for advanced medical stopcocks is increasing. Thus, the surge in surgical procedures is driving the Middle East & Africa advanced medical stopcock market.

On the contrary, security concerns about stopcocks hurdles the growth of Middle East & Africa advanced medical stopcock market.

Based on type, the Middle East & Africa advanced medical stopcock market is categorized into low-pressure stopcock, medium-pressure stopcock, and high-pressure stopcock. The low-pressure stopcock segment held 56.4% market share in 2022, amassing US$ 53.17 million. It is projected to garner US$ 68.85 million by 2028 to expand at 4.4% CAGR during 2022–2028.

Based on end user, the Middle East & Africa advanced medical stopcock market is categorized into hospitals & clinics, ambulatory surgical centers, and homecare. The hospitals & clinics segment held 49.3% market share in 2022, amassing US$ 46.53 million. It is projected to garner US$ 61.03 million by 2028 to expand at 4.6% CAGR during 2022–2028.

Based on country, the Middle East & Africa advanced medical stopcock market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa.  Our regional analysis states that Saudi Arabia captured 41.2% market share in 2022. It was assessed at US$ 38.88 million in 2022 and is likely to hit US$ 50.24 million by 2028, exhibiting a CAGR of 4.4% during the forecast period.

Key players dominating the Middle East & Africa advanced medical stopcock market are B. Braun SE; Smiths Medical Inc; Nipro Corp; Elcam Medical Group Co.; Merit Medical Systems Inc.; Nordson Corp; and Utah Medical Products Inc among others.

• In Aug 2019, Smiths Medical announces partnership with Medline Industries, Inc.
• In Jan 2022, B. Braun expands footprint in Vietnam with ground-breaking of new factory.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com